相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Adeno-associated virus type 2 contains an integrin α5β1 binding domain essential for viral cell entry
Aravind Asokan et al.
JOURNAL OF VIROLOGY (2006)
Recombinant adeno-associated virus serotype 9 leads to preferential cardiac transduction in vivo
Christina A. Pacak et al.
CIRCULATION RESEARCH (2006)
Robust systemic transduction with AAV9 vectors in mice: Efficient global cardiac gene transfer superior to that of AAV8
Katsuya Inagaki et al.
MOLECULAR THERAPY (2006)
Vascular bed-targeted in vivo gene delivery using tropism-modified adeno-associated viruses
LM Work et al.
MOLECULAR THERAPY (2006)
Human immunoglobulin inhibits liver transduction by AAV vectors at low AAV2 neutralizing titers in SCID mice
CD Scallan et al.
BLOOD (2006)
Adeno-associated virus serotype 8 efficiently delivers genes to muscle and heart
Z Wang et al.
NATURE BIOTECHNOLOGY (2005)
Hepatocyte growth factor receptor is a coreceptor for adeno-associated virus type 2 infection
Y Kashiwakura et al.
JOURNAL OF VIROLOGY (2005)
Rapid uncoating of vector genomes is the key to efficient liver transduction with pseudotyped adeno-associated virus vectors
CE Thomas et al.
JOURNAL OF VIROLOGY (2004)
Targeted gene delivery to vascular tissue in vivo by tropism-modified adeno-associated virus vectors
SJ White et al.
CIRCULATION (2004)
Systemic delivery of genes to striated muscles using adeno-associated viral vectors
P Gregorevic et al.
NATURE MEDICINE (2004)
Efficient transduction of skeletal muscle using vectors based on adeno-associated virus serotype 6
MJ Blankinship et al.
MOLECULAR THERAPY (2004)
Genetic modifications of the adeno-associated virus type 2 capsid reduce the affinity and the neutralizing effects of human serum antibodies
NA Huttner et al.
GENE THERAPY (2003)
Random peptide libraries displayed on adeno-associated virus to select for targeted gene therapy vectors
OJ Müller et al.
NATURE BIOTECHNOLOGY (2003)
Targeting recombinant adeno-associated virus vectors to enhance gene transfer to pancreatic islets and liver
SA Loiler et al.
GENE THERAPY (2003)
SWISS-MODEL: an automated protein homology-modeling server
T Schwede et al.
NUCLEIC ACIDS RESEARCH (2003)
The atomic structure of adeno-associated virus (AAV-2), a vector for human gene therapy
Q Xie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Recognition of cell-specific binding of phage display derived peptides using an acoustic wave sensor
AM Samoylov et al.
BIOMOLECULAR ENGINEERING (2002)
Insertional mutagenesis of the adeno-associated virus type 2 (AAV2) capsid gene and generation of AAV2 vectors targeted to alternative cell-surface receptors
WF Shi et al.
HUMAN GENE THERAPY (2001)
Efficient and selective AAV2-mediated gene transfer directed to human vascular endothelial cells
SA Nicklin et al.
MOLECULAR THERAPY (2001)
Incorporation of tumor-targeting peptides into recombinant adeno-associated virus capsids
M Grifman et al.
MOLECULAR THERAPY (2001)
Cell surface heparan sulfate proteoglycans: Selective regulators of ligand-receptor encounters
PW Park et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector
MA Kay et al.
NATURE GENETICS (2000)
AAV vectors: is clinical success on the horizon?
PE Monahan et al.
GENE THERAPY (2000)
Mutational analysis of the adeno-associated virus type 2 (AAV2) capsid gene and construction of AAV2 vectors with altered tropism
P Wu et al.
JOURNAL OF VIROLOGY (2000)
分享论文
